(1553021) ZMYM3 Mutations Dysregulate Histone Acetylation and Impact the Outcome Of Chronic Lymphocytic Leukemia Patients

Primary Author; Presenting Author(s)

• 

  Alberto Rodríguez Sánchez, BSc

  PhD student
  Cancer Research Center, USAL, Spain

  Slides

Co-Author(s)

• MQ

  Miguel Quijada Álamo, PhD

  Post-Doctoral Researcher
  University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center. Department of Hematology, University Hospital of Salamanca
  Salamanca, Spain
• 

  Claudia Pérez Carretero, PhD

  Post-Doctoral Researcher
  University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center. Department of Hematology, University Hospital of Salamanca
  Salamanca, Spain
• LC

  Luis A. Corchete Sánchez, PhD

  Post-Doctoral Researcher
  Massachusetts General Hospital Center for Cancer Research, Charlestown, MA 02129; Harvard Medical School, Boston, MA 02215; Broad Institute of MIT and Harvard, Cambridge, MA 02139
  Boston, MA, United States
• CM

  Cristina Miguel García, BSc

  University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center. Department of Hematology, University Hospital of Salamanca, Salamanca
  Salamanca, Spain
• SS

  Sandra Santos Mínguez, BSc

  University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center. Department of Hematology, University Hospital of Salamanca, Salamanca
  Salamanca, Spain
• EL

  Eva Lumbreras González, BSc

  University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center. Department of Hematology, University Hospital of Salamanca, Salamanca
  Salamanca, Spain
• JD

  Julio Dávila Valls, BSc

  Hematologist
  Department of Hematology, Hospital Nuestra Señora de Sonsoles
  Ávila, Spain
• AG

  Alfonso García De Coca

  Hematologist
  Department of Hematology. Hospital Clínico, Valladolid, Spain
• MV

  María Jesús Vidal Manceñido, PhD

  Hematologist
  Hospital de León
  León, Castilla y Leon, France
• RB

  Rocío Benito Sánchez, PhD

  Post-Doctoral Researcher
  University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center. Department of Hematology, University Hospital of Salamanca
  Salamanca, Spain
• AR

  Ana E Rodríguez Vicente, PhD

  University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center. Department of Hematology, University Hospital of Salamanca
  Salamanca, Spain
• JH

  Jesús María Hernández Rivas, MD, PhD

  Hematologist, Principal Researcher
  University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain; Department of Hematology, University Hospital of Salamanca
  Salamanca, Spain